The S&P / ASX 200 (Index: ^AXJO) (ASX: XJO) is in positive territory this lunchtime although still a long way off replicating the record highs U.S. equity markets have been hitting this week.
However, several ASX-listed stocks are hitting their own record highs with big future potential that means they're worth a closer look.
M2 Group Ltd (ASX: MTU) is a telecommunications, internet and utility services retailer that has climbed more than 2.4% to a record high of $8.34 today after providing a positive update at its recent AGM.
The group's shares have now roughly tripled in value over the past three years, with its debt-funded acquisition strategy paying off handsomely alongside some spectacular organic growth. M2's biggest strength might be its brilliant management team's unrelenting focus on growing the business and shareholder returns. Any pullback in price looks a buying opportunity.
My Net Fone Limited (ASX: MNF) has climbed 5% to a record high of $3.78 today. Its $225 million market cap is around one fifth the size of M2 Group, although My Net Fone has a futuristic service offering that gives it potential to reach M2's size one day.
The company provides internet-based telecommunication services to private businesses and large public sector organisations such as the Tasmanian government.
One key advantage of using voice communications over the internet for large private or public sector organisations is that all staff can effectively switch desks, buildings, or even countries without having to undertake the burdensome process of switching phone numbers. My Net Fone is growing fast and with potential to win many more clients it's no surprise investors are bidding up the share price.
Pro Medicus Limited (ASX: PME) has climbed 11.5 cents to hit a 52-week high of 99 cents today as investors warm to its potential to provide IT and software solutions to the private healthcare industry globally.
The business appears to have a strong tailwind because governments worldwide are struggling to pay for their ageing populations healthcare. The resulting structural shift towards private healthcare means technology companies that can help the private sector deliver healthcare for less money may be big future winners.
Sirtex Medical Limited (ASX: SRX) is another globally-focused medical business that has seen its shares hit a record high of $27.25. Although Sirtex relies on government rebates for much of its revenues healthcare spending is growing globally, and Sirtex's core radiation-therapy product has a big growth horizon.
The company hopes March 2015 will see positive results from a major clinical trial it is conducting to prove the effectiveness of its product in fighting early or mid-stage liver cancer in patients. The treatment is currently used primarily as a last resort, but its elevation to first-line status could see dose sales get a major boost.
Those are four top stocks worth keeping an eye on, but I don't think they offer as much value as The Motely Fool's top stock for 2015!
